The Introduction of IBFG
 Shanghai
Institute of Brain Functional Genomics (IBFG) was founded at East
China Normal University in October 2002. The institute occupies
a 4000 square meters building fully equipped with state of the art
facilities. The major scientific focus of IBFG is on cognitive neuroscience
and brain aging. The ultimate goal of IBFG is to understand the
mechanisms of learning and memory, brain aging and age-associated
brain diseases from molecular to neural network levels, and to identify
targets and strategies for treating CNS diseases. Towards these
goals, the institute has established six coherent, core technological
platforms, including Genome-wide gene expression analysis platform,
Proteomics platform, Transgenic animal model development platform,
Animal model phenotype analysis platform, High-density in vivo ensemble
recording and computational analysis platform, and CNS drug development
platform.
 The
institute is funded by Ministry of Science and Technology, Ministry
of Education, Science and Technology Commission of Shanghai Municipality,
Education Commission of Shanghai Municipality and East China Normal
University. As one of the key laboratories of Ministry of Education
and Shanghai Municipality, IBFG offers a collaborative environment
where researchers from other institutions in China or abroad meet
regularly and work together toward the common goal. The main focus
of IBFG is to conduct basic neuroscience research and to encourage
high-quality publication in peer-reviewed international journals.
In addition, IBFG has built the largest compound library from Traditional
Chinese Medicine extracts and through high-through-put screening,
is also actively developing therapeutic compounds for treating Alzheimer’s
disease, brain aging and obesity. The institute encourages commercialization
and collaborations with pharmaceuticals and biotechnology companies.
|
|
